Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v5-FR
Language French French
Date Updated 2017-08-03 2017-08-03
Drug Identification Number 02292297 02292297
Brand name CEFTRIAXONE FOR INJECTION USP CEFTRIAXONE FOR INJECTION USP
Common or Proper name ROCEPHIN ROCEPHIN
Company Name SANDOZ CANADA INCORPORATED SANDOZ CANADA INCORPORATED
Ingredients CEFTRIAXONE CEFTRIAXONE
Strength(s) 10.0G 10.0G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 10g VIAL 10g VIAL
ATC code J01DD J01DD
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2017-04-11 2017-04-11
Estimated end date 2017-04-28 2017-04-28
Actual end date 2017-05-05 2017-05-05
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments
Health Canada comments